Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitors

Anne Thiry, Aurélie Delayen, Laurence Goossens, Raymond Houssin, Marie Ledecq, Aurélie Frankart, Jean-Michel Dogné, Johan Wouters, Claudiu T Supuran, Jean-Pierre Hénichart, Bernard Masereel

Research output: Contribution to journalArticlepeer-review

Abstract

We report the synthesis and the pharmacological evaluation of a new class of human carbonic anhydrase (hCA) inhibitors prepared regio- and stereoselectively by reacting sulfanilamide with ethyl trans-phenylglycidate in the presence of cobalt(II) chloride. Various derivatizations of the ester moiety in the parent compound led to a small library of derivatives (2R,3R and 2S,3S) which displayed interesting inhibitory activities towards the human tumor-associated isoform CA IX. One of the new compounds shows high selectivity in inhibiting hCA IX compared to the two physiologically relevant, cytosolic isozymes hCA I and hCA II. A molecular modeling study was conducted in order to simulate the binding mode of this new family of enzyme inhibitors within the active sites of hCA IX and hCA II.
Original languageEnglish
Pages (from-to)511-8
Number of pages8
JournalEuropean Journal of Medicinal Chemistry
Volume44
Issue number2
DOIs
Publication statusPublished - 1 Feb 2009

Keywords

  • Carbonic anhydrase
  • Molecular modeling
  • Sulfonamide
  • Tumor-associated isoform

Fingerprint

Dive into the research topics of 'Synthesis and biological evaluation of a new family of anti-benzylanilinosulfonamides as CA IX inhibitors'. Together they form a unique fingerprint.

Cite this